Evaluation of a Clinical Decision Support System for Fungal Infections
- Conditions
- Invasive Fungal Infections
- Interventions
- Device: Medical device
- Registration Number
- NCT05656157
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Invasive fungal infections are serious and frequent diseases in our hospitals, especially in intensive care units. In accordance with the institutional recommendations, it is necessary to have a clinical decision support system to support the clinicians in a rapid and optimal prescription of antifungals for invasive fungal diseases. This clinical decision support system will benefit patients but also clinicians who will gain in medical efficiency. It will also have an ethical dimension since it will guarantee optimal antifungal treatments for all patients. The purpose of the research is to define the percentage of concordance between the medical prescription and the recommendation of the clinical decision support system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 278
- Patients receiving antifungal therapy for the treatment of invasive fungal disease
- Patients not receiving antifungal therapy for the treatment of invasive fungal disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Antifungal treatment recommended by the clinical decision support system Medical device -
- Primary Outcome Measures
Name Time Method Percentage of concordance between the medical prescription and the recommendation of the clinical decision support system January to september 2023
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospices Civils de Lyon
🇫🇷Lyon, France